The global Peripheral Artery Disease Market was valued at USD 5.22 billion in 2024 and is projected to grow from USD 5.66 billion in 2025 to USD 10.75 billion by 2033, registering a CAGR of 8.35% during the forecast period (2025–2033).
Peripheral artery disease (PAD) is a circulatory condition caused by plaque buildup in arteries that restricts blood flow to the limbs, brain, kidneys, and other organs. The disease most commonly affects arteries in the legs and is increasingly becoming a major healthcare concern worldwide due to rising incidences of diabetes, hypertension, obesity, smoking, and cardiovascular disorders.
The growing elderly population, advancements in minimally invasive treatment procedures, increasing healthcare expenditure, and favorable reimbursement policies are significantly contributing to market expansion. In addition, the growing adoption of advanced medical devices such as drug-eluting stents, atherectomy systems, and drug-coated balloons is accelerating market growth globally.
Increasing Burden of Chronic Diseases Supports Market Expansion
The rapid increase in the aging population worldwide remains one of the key factors driving the peripheral artery disease market. Older adults are more susceptible to chronic illnesses such as diabetes, hypertension, and hypercholesterolemia, all of which increase the risk of developing PAD.
According to industry estimates, peripheral artery disease affects millions of individuals globally, especially adults over the age of 50. Sedentary lifestyles, smoking habits, unhealthy dietary patterns, and lack of physical activity are further increasing the prevalence of vascular disorders.
Healthcare authorities and governments across several countries are also focusing on improving access to quality healthcare services through enhanced insurance coverage and reimbursement policies. Emerging economies including India, China, and Brazil are expanding public healthcare infrastructure and promoting affordable treatment accessibility, which is positively influencing market growth.
Technological Innovations Transform PAD Treatment Landscape
Technological advancements in vascular intervention devices are reshaping the treatment landscape for peripheral artery disease. Medical device manufacturers are increasingly investing in the development of next-generation treatment products that offer improved clinical outcomes and reduced risk of restenosis.
Innovative solutions such as bio-engineered stents, EPC capture stents, dual therapy stents, orbital atherectomy systems, and drug-coated balloons are gaining significant attention among healthcare providers. These technologies are designed to restore blood flow effectively while minimizing vessel damage and reducing the need for repeat procedures.
Drug-coated balloons, in particular, are witnessing increased adoption due to their ability to deliver antiproliferative drugs directly to vessel walls without leaving permanent implants. The growing preference for minimally invasive endovascular procedures such as angioplasty and atherectomy over traditional bypass surgery is expected to further fuel market growth during the forecast period.
However, complications associated with restenosis continue to remain a major challenge for the industry. Restenosis, which refers to the re-narrowing of arteries following angioplasty procedures, often results in clinical failures and repeat interventions, especially among diabetic patients.
North America Dominates the Global Market
Europe and Asia-Pacific Witness Significant Growth Opportunities
North America accounted for the largest share of the global peripheral artery disease market and is expected to grow at a CAGR of 7.5% during the forecast period. The region’s dominance is attributed to the increasing prevalence of diabetes, hypertension, obesity, and cardiovascular diseases, along with advanced healthcare infrastructure and high adoption of innovative treatment devices.
The growing use of peripheral angioplasty balloons, stents, catheters, plaque modification devices, and hemodynamic flow alteration devices is further supporting market expansion across the United States and Canada.
Europe is anticipated to witness robust growth at a CAGR of 8.4%, driven by rising smoking rates, increasing cardiovascular disease cases, and an aging population. Countries such as Germany, France, and the United Kingdom are focusing heavily on early diagnosis and advanced treatment technologies for vascular diseases.
Asia-Pacific is projected to register the fastest growth rate of 9.45% during the forecast period due to rising healthcare investments, expanding insurance coverage, and increasing awareness regarding vascular health. Rapid urbanization, lifestyle changes, and growing disposable incomes in countries like China and India are creating strong growth opportunities for market players.
Meanwhile, the LAMEA region is expected to experience steady growth owing to improving healthcare infrastructure, rising healthcare expenditure, and increasing investments by international medical device manufacturers.
Peripheral Stents Segment Holds Major Market Share
Demand for Minimally Invasive Procedures Continues to Rise
Based on type, the peripheral stents segment dominates the market and is expected to grow at a CAGR of 7.5% during the forecast period. Peripheral stents are widely used to treat narrowed or blocked arteries and improve blood circulation. The development of drug-eluting and bio-engineered stents has significantly improved treatment efficiency and patient outcomes.
The peripheral angioplasty balloons segment is also anticipated to witness substantial growth due to increasing demand for minimally invasive angioplasty procedures. Rising incidences of diabetes, high cholesterol, and cardiac diseases are expected to boost demand for angioplasty devices globally.
Hospitals and clinics remain the primary end users of PAD treatment devices owing to the availability of advanced diagnostic technologies and specialized healthcare professionals.
Key Players in the Peripheral Artery Disease Market
Leading Companies Focus on Innovation and Strategic Expansion
- Abbott Laboratories
- Cardinal Health, Inc.
- Boston Scientific Corporation
- Cook Medical
- Becton Dickinson and Company
- Terumo Corporation
- Koninklijke Philips N.V.
- AngioDynamics, Inc.
- BIOTRONIK
- B. Braun Melsungen AG
Recent industry developments continue to strengthen the competitive landscape. In January 2022, Abbott Laboratories introduced a new biowearables category designed to monitor glucose, ketones, and alcohol levels for improved health tracking. In July 2022, Terumo India entered a strategic partnership with Sensible Medical Innovations for the commercial distribution of ReDS Pro in India.
Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Market Report Overview here: https://straitsresearch.com/report/peripheral-artery-disease-market
About Straits Research
Straits Research is a global market research and consulting company delivering actionable business insights, industry intelligence, and customized research solutions across diverse sectors. The company provides comprehensive market reports, competitive analysis, and strategic forecasting to support organizations in making informed business decisions and identifying emerging growth opportunities worldwide.
